Innate immunity in experimental autoimmune myocarditis

Molecular Autoimmunity

Volumn , Issue , 2005, Pages 1-15

  Kaya, Ziya ^a   Rose, Noel R ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 51849137825     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/0-387-24534-0_1     Document Type: Chapter

References (76)

1. Afanasyeva, M., Georgakopoulos, D., Belardi, D.F., Bedja D., Fairweather, D., Wang, Y., Kaya, Z., Gabrielson, K.L., Rodriguez, E.R., Caturegli, P., Kass, D.A., and Rose, N.R. (2005). Impaired up-regulation of CD25 on CD4+ T cells in IFN-gamma knockout mice is associated with progression of myocarditis to heart failure. Proc. Natl. Acad. Sci., 102, 180-185.
2. Afanasyeva, M., Georgakopoulos, D., Belardi, D.F., Ramsundar, A.C., Barin, J.G., Kass, D.A., and Rose, N.R. (2004). Quantitative analysis of myocardial inflammation by flow cytometry in murine autoimmune myocarditis. Am. J. Pathol., 164, 807-815.
3. Afanasyeva, M., Georgakopoulos, D., and Rose, N.R. (2004). Autoimmune myocarditis: cellular mediators of cardiac dysfunction. Autoimmun. Rev., 3, 476-486.
4. Afanasyeva, M. and Rose, N.R. (2002a). Immune mediators in inflammatory heart disease: Insights from a mouse model. Eur. Heart J., 4 (Suppl. 1), 131-146.
5. Afanasyeva, M. and Rose, N.R. (2002b). Cardiomyopathy is linked to complement activation. Am. J. Pathol., 161, 351-357.
6. Afanasyeva, M. and Rose, N.R. (2004). Viral infection and heart disease: autoimmune mechanisms. In: Y. Shoenfeld and N.R. Rose. (eds), Infection and Autoimmunity. Elsevier, Amsterdam. pp. 299-318.
7. Afanasyeva, M., Wang, Y., Kaya, Z., Park, S., Zilliox, M.J., Schofield, B.H., Hill, S.L., and Rose, N.R. (2001b). Experimental autoimmune myocarditis in A/J mice is an interleukin-4-dependent disease with a Th2 phenotype. Am. J. Pathol., 159, 193-203.
8. Afanasyeva, M., Wang, Y., Kaya, Z., Stafford, E.A., Dohmen, K.M., Sadighi Akha, A.A., and Rose, N.R. (2001a). Interleukin-12 receptor/STAT4 signaling is required for the development of autoimmune myocarditis in mice by an interferon-gamma-independent pathway. Circulation, 104, 3145-3151.
9. Bachmaier, K., Pummerer, C., Shahinian, A., Ionescu, J., Neu, N., Mak, T.W., and Penninger, J.M. (1996). Induction of autoimmunity in the absence of CD28 costimulation. J. Immunol., 157, 1752-1757.
10. Badorff, C., Berkely, N., Mehrotra, S., Talhouk, J.W., Rhoads, R.E., and Knowlton, K.U. (2000). Enteroviral protease 2A directly cleaves dystrophin and is inhibited by a dystrophin-based substrate analogue. J. Biol. Chem., 275, 11191-11197.
11. Badorff, C., Lee, G.H., Lamphear, B.J., Martone, M.E., Campbell, K.P., Rhoads, R.E., and Knowlton, K.U. (1999). Enteroviral protease 2A cleaves dystrophin: Evidence of cytoskeletal disruption in an acquired cardiomyopathy. Nat. Med., 5, 320-326.
12. Caforio, A.L., Mahon, N.J., and Mckenna, W.J. (2001). Cardiac autoantibodies to myosin and other heartspecific autoantigens in myocarditis and dilated cardiomyopathy. Autoimmunity, 34, 199-204.
13. Carroll, M.C. (1998). The role of complement and complement receptors in induction and regulation of immunity. Annu. Rev. Immunol., 16, 545-568.
14. Cunningham, M.W. (2004). T cell mimicry in inflammatory heart disease. Mol. Immunol., 40, 1121-1127.
15. Davoust, N., Nataf, S., Reiman, R., Holers, M.V., Campbell, I.L., and Barnum, S.R. (1999). Central nervous system-targeted expression of the complement inhibitor sCrry prevents experimental allergic encephalomyelitis. J. Immunol., 163, 6551-6556.
16. Delibrias, C.C., Fischer, E., Bismuth, G., and Kazatchkine, M.D. (1992). Expression, molecular association, and functions of C3 complement receptors CR1 (CD35) and CR2 (CD21) on the human T cell line HPB-ALL. J. Immunol., 149, 768-774.
17. Delibrias, C.C., Mouhoub, A., Fischer, E., and Kazatchkine, M.D. (1994). CR1(CD35) and CR2(CD21) complement C3 receptors are expressed on normal human thymocytes and mediate infection of thymocytes with opsonized human immunodeficiency virus. Eur. J. Immunol., 24, 2784-2788.
18. Donath, J. and Landsteiner, K. (1904). Ueber paroxysmale hemoglobinurie. Z. Klin. Med., 58, 173-189.
19. Donermeyer, D.L., Beisel, K.W., Allen, P.M., and Smith, S.C. (1995). Myocarditis-inducing epitope of myosin binds constitutively and stably to I-Ak on antigen-presenting cells in the heart. J. Exp. Med., 182, 1291-1300.
20. Egashira, K. (2003). Molecular mechanisms mediating inflammation in vascular disease: Special reference to monocyte chemoattractant protein-1. Hypertension, 41, 834-841.
21. Eriksson, U., Kurrer, M.O., Schmitz, N., Marsch, S.C., Fontana, A., Eugster, H.P., and Kopf, M.U. (2003a). Interleukin-6-deficient mice resist development of autoimmune myocarditis associated with impaired upregulation of complement C3. Circulation, 107, 320-325.
22. Eriksson, U., Kurrer, M.O., Sonderegger, I., and Iezzi, G. (2003b). Activation of dendritic cells through the interleukin 1 receptor 1 is critical for the induction of autoimmune myocarditis. J. Exp. Med., 197, 323-331.
23. Fairweather, D., Afanasyeva, M., and Rose, N.R. (2004). Cellular immunity: A role for cytokines. In A. Doria and P. Pauletto (eds), Handbook of Systemic Autoimmune Diseases. Vol 1: The Heart in Systemic Autoimmune Diseases. Elsevier, Amsterdam. pp. 3-17.
24. Fairweather, D., Frisancho-Kiss, S., Gatewood, S., Njoku, D., Steele, R., Barrett, M., and Rose, N.R. (2004). Mast cells and innate cytokines are associated with susceptibility to autoimmune heart disease following Coxsackievirus B3 infection. Autoimmunity, 37, 131-145.
25. Fairweather, D., Kaya, Z., Shellam, G.R., Lawson, C.M., and Rose, N.R. (2001). From infection to autoimmunity. J. Autoimmun., 16, 175-186.
26. Fairweather, D., Yusung, S., Frisancho, S., Barrett, M., Gatewood, S., Steele, R., and Rose, N.R. (2003). IL-12 receptor beta 1 and toll-like receptor 4 increase IL-1 beta- and IL-18-Associated myocarditis and coxsackievirus replication. J. Immunol., 170, 4731-4737.
27. Fischer, E., Delibrias, C., and Kazatchkine, M.D. (1991). Expression of CR2 (the C3dg/EBV receptor, CD21) on normal human peripheral blood T lymphocytes. J. Immunol., 146, 865-869.
28. Furuichi, K., Wada, T., Iwata, Y., Kitagawa, K., Kobayashi, K., Hashimoto, H., Ishiwata, Y., Tomosugi, N., Mukaida, N., Matsushima, K., Egashira, K., and Yokoyama, H. (2003). Gene therapy expressing amino-terminal truncated monocyte chemoattractant protein-1 prevents renal ischemiareperfusion injury. J. Am. Soc. Nephrol., 14, 1066-1071.
29. Fuse, K., Kodama, M., Hanawa, H., Okura, Y., Ito, M., Shiono, T., Maruyama, S., Hirono, S., Kato, K., Watanabe, K., and Aizawa, Y. (2001a). Enhanced expression and production of monocyte chemoattractant protein-1 in myocarditis. Clin. Exp. Immunol., 124, 346-352.
30. Fuse, K., Kodama, M., Aizawa, Y., Yamaura, M., Tanabe, Y., Takahashi, K., Sakai, K., Miida, T., Oda, H., and Higuma, N. (2001b). Th1/Th2 balance alteration in the clinical course of a patient with acute viral myocarditis. Circ. J., 65, 1082-1084.
31. Gauntt, C.J., Arizpe, H.M., Higdon, A.L., Wood, H.J., Bowers, D.F., Rozek, M.M., and Crawley, R. (1995). Molecular mimicry, anti-coxsackievirus B3 neutralizing monoclonal antibodies, and myocarditis. J. Immunol., 154, 2983-2995.
32. Godeny, E.K. and Gauntt, C.J. (1986). Involvement of natural killer cells in coxsackievirus B3- induced murine myocarditis. J. Immunol., 137, 1695-1702.
33. Godeny, E.K. and Gauntt, C.J. (1987). Murine natural killer cells limit coxsackievirus B3 replication. J. Immunol., 139, 913-918.
34. Guler, M.L., Ligons, D.L., Wang, Y., Bianco, M., Broman, K.W., and Rose, N.R. (2005). Two autoimmune diabetes loci influencing T cell apoptosis control susceptibility to experimental autoimmune myocarditis. J. Immunol., 174, 2167-2173.
35. Hill, S.L. and Rose, N.R. (2001). The transition from viral to autoimmune myocarditis. Autoimmunity, 34, 169-176.
36. Horwitz, M.S., La Cava, A., Fine, C., Rodriguez, E., Ilic, A., and Sarvetnick, N. (2000). Pancreatic expression of interferon-gamma protects mice from lethal coxsackievirus B3 infection and subsequent myocarditis. Nat. Med., 6, 631-632.
37. Ikeda, Y., Yonemitsu, Y., Kataoka, C., Kitamoto, S., Yamaoka, T., Nishida, K., Takeshita, A., Egashira, K., and Sueishi, K. (2002). Anti-monocyte chemoattractant protein-1 gene therapy attenuates pulmonary hypertension in rats. Am. J. Heart Circ. Physiol., 283, H2021-H2028.
38. Inomata, T., Hanawa, H., Miyanishi, T., Yajima, E., Nakayama, S., Maita, T., Kodama, M., Izumi, T., Shibata, A., and Abo, T. (1995). Localization of porcine cardiac myosin epitopes that induce experimental autoimmune myocarditis. Circ. Res., 76, 726-733.
39. Kaya, Z., Afanasyeva, M., Wang, Y., Dohmen, K.M., Schlichting, J., Tretter, T., Fairweather, D., Holers, V.M., and Rose, N.R. (2001). Contribution of the innate immune system to autoimmune myocarditis: A role for complement. Nat. Immunol., 2, 739-745.
40. Kaya, Z., Dohmen, K.M., Wang, Y., Schlichting, J., Afanasyeva, M., Leuschner, F., and Rose, N.R. (2002). Cutting edge: A critical role for IL-10 in induction of nasal tolerance in experimental autoimmune myocarditis. J. Immunol., 168, 1552-1556.
41. Kaya, Z., Göser, S., Öttl, R., Brodner, A., Dengler, T.J., Egashira, K., Kuziel, W.A., and Katus, H.A. (2005) (in press). Critical role for MCP-1 and MIP-1a in the induction of EAM and anti-MCP-1 gene therapy. FASEB J., abstract.
42. Kaya, Z., Tretter, T., Schlichting, J., Leuschner, F., Afanasyeva, M., Katus, H.A., and Rose, N.R. (2005). Complement receptors regulate lipopolysaccharide-induced T-cell stimulation. Immunology, 114, 493-498.
43. Kerekes, K., Prechl, J., Bajtay, Z., Jozsi, M., and Erdei, A. (1993). A further link between innate and adaptive immunity: C3 deposition on antigen-presenting cells enhances the proliferation of antigen-specific T cells. Int. Immunol., 10, 1923-1930.
44. Kinoshita, T., Takeda, J., Hong, K., Kozono, H., Sakai, H., and Inoue, K. (1988). Monoclonal antibodies to mouse complement receptor type 1 (CR1). Their use in a distribution study showing that mouse erythrocytes and platelets are CR1-negative. J. Immunol., 140, 3066-3072.
45. Kitamoto, S. and Egashira, K. (2003). Anti-monocyte chemoattractant protein-1 gene therapy for cardiovascular diseases. Exp. Rev. Card. Ther., 1, 393-400.
46. Kohno, K., Takagaki, Y., Nakajima, Y., and Izumi, T. (2000). Advantage of recombinant technology for the identification of cardiac myosin epitope of severe autoimmune myocarditis in Lewis rats. Jpn. Heart J., 41, 67-77.
47. Kolattukudy, P.E., Quach, T., Bergese, S., Breckenridge, S., Hensley, J., Altschuld, R., Gordillo, G., Klenotic, S., Orosz, C., and Parker-Thornburg, J. (1998). Myocarditis induced by targeted expression of the MCP-1 gene in murine cardiac muscle. Am. J. Pathol., 152, 101-111.
48. Kuhn, R.J. (1997). Identification and biology of cellular receptors for the coxsackie B viruses group. Curr. Top. Microbiol. Immunol., 223, 209-226.
49. Lane, J.R., Neumann, D.A., Lafond-Walker, A., Herskowitz, A., and Rose, N.R. (1992). Interleukin 1 or tumor necrosis factor can promote coxsackie B3-induced myocarditis in resistant B10. A mice. J. Exp. Med., 175, 1123-1129.
50. Lane, J.R., Neumann, D.A., Lafond-Walker, A., Herskowitz, A., and Rose, N.R. (1993). Role of IL-1 and tumor necrosis factor in coxsackie virus-induced autoimmune myocarditis. J. Immunol., 151, 1682-1690.
51. Lehmann, M.H., Kuhnert, H., Muller, S., and Sigusch, H.H. (1998). Monocyte chemoattractant protein 1 (MCP-1) gene expression in dilated cardiomyopathy. Cytokine, 10, 739-746.
52. Leiden, J.M. (1997). The genetics of dilated cardiomyopathy-emerging clues to the puzzle. New Engl. J. Med., 337, 1080-1081.
53. Liao, L., Sindhwani, R., Leinwand, L., Diamond, B., and Factor, S. (1993). Cardiac alpha-myosin heavy chains differ in their induction of myocarditis. Identification of pathogenic epitopes. J. Clin. Invest., 92, 2877-2882.
54. Liao, L., Sindhwani, R., Rojkind, M., Factor, S., Leinwand, L., and Diamond, B. (1995). Antibodymediated autoimmune myocarditis depends on genetically determined target organ sensitivity. J. Exp. Med., 181, 1123-1131.
55. Liu, P., Aitken, K., Kong, Y.Y., Opavsky, M.A., Martino, T., Dawood, F., Wen, W.H., Kozieradzki, I., Bachmaier, K., Straus, D., Mak, T.W., and Penninger, J.M. (2000). The tyrosine kinase p56lck is essential in coxsackievirus B3-mediated heart disease. Nat. Med., 6, 429-434.
56. Martino, T.A., Petric, M., Brown, M., Aitken, K., Gauntt, C.J., Richardson, C.D., Chow, L.H., and Liu, P.P. (1998). Cardiovirulent coxsackieviruses and the decay-Accelerating factor (CD55) receptor. Virology, 244, 302-314.
57. Morgan, B.P. and Walport, M.J. (1991). Complement deficiency and disease. Immunol. Today, 12, 301-306.
58. Nelson, D.P., Setser, E., Hall, D.G., Schwartz, S.M., Hewitt, T., Klevitsky, R., Osinska, H., Bellgrau, D., Duke, R.C., and Robbins, J. (2000). Proinflammatory consequences of transgenic fas ligand expression in the heart. J. Clin. Invest., 105, 1199-1208.
59. Neu, N., Beisel, K.W., Traystman, M.D., Rose, N.R., and Craig, S.W. (1987a). Autoantibodies specific for the cardiac myosin isoform are found in mice susceptible to coxsackievirus B3-induced myocarditis. J. Immunol., 138, 2488-2492.
60. Neu, N., Rose, N.R., Beisel, K.W., Herskowitz, A., Gurri-Glass, G., and Craig, S.W. (1987b). Cardiac myosin induces myocarditis in genetically predisposed mice. J. Immunol., 139, 3630-3636.
61. Neumann, D.A., Lane, J.R., LaFond-Walker, A., Allen, G.S., Frondoza, C., Herskowitz, A., and Rose, N.R. (1991). Elution of autoantibodies from the hearts of coxsackie-virus-infected mice. Eur. Heart J., 12 (Suppl. D), 113-116.
62. Neumann, D.A., Lane, J.R., Allen, G.S., Herskowitz, A., and Rose, N.R. (1993). Viral myocarditis leading to cardiomyopathy: Do cytokines contribute to pathogenesis? Clin. Immunol. Immunopathol., 68, 181-190.
63. Nishimura, H., Okazaki, T., Tanaka, Y., Nakatani, K., Hara, M., Matsumori, A., Sasayama, S., Mizoguchi, A., Hiai, H., Minato, N., and Honjo, T. (2001). Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science, 291, 319-322.
64. Okazaki, T., Tanaka, Y., Nishio, R., Mitsuiye, T., Mizoguchi, A., Wang, J., Ishida, M., Hiai, H., Matsumori, A., Minato, N., and Honjo, T. (2003). Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice. Nat. Med., 9, 1477-1483.
65. Penninger, J.M., Neu, N., Timms, E., Wallace, V.A., Koh, D.R., Kishihara, K., Pummerer, C., and Mak, T.W. (1993). The induction of experimental autoimmune myocarditis in mice lacking CD4 or CD8 molecules [corrected]. J. Exp. Med., 178, 1837-1842.
66. Pratt, J.R., Basheer, S.A., and Sacks, S.H. (2002). Local synthesis of complement component C3 regulates acute renal transplant rejection. Nat. Med., 8, 582-587.
67. Pummerer, C.L., Luze, K., Grassl, G., Bachmaier, K., Offner, F., Burrell, S.K., Lenz, D.M., Zamborelli, T.J., Penninger, J.M., and Neu, N. (1996). Identification of cardiac myosin peptides capable of inducing autoimmune myocarditis in BALB/c mice. J. Clin. Invest., 97, 2057-2062.
68. Rose, N.R., Herskowitz, A., Neumann, D.A., and Neu, N. (1988a). Autoimmune myocarditis: A paradigm of post-infection autoimmune disease. Immunol. Today, 9, 117-119.
69. Rose, N.R., Neumann, D.A., Herskowitz, A., Traystman, M.D., and Beisel, K.W. (1988b). Genetics of susceptibility to viral myocarditis in mice. Pathol. Immunopathol. Res., 7, 266-278.
70. Salazar-Mather, T.P., Orange, J.S., and Biron, C.A. (1998). Early murine cytomegalovirus (MCMV) infection induces liver natural killer (NK) cell inflammation and protection through macrophage inflammatory protein 1alpha (MIP-1alpha)-dependent pathways. J. Exp. Med., 187, 1-14.
71. Shimizu, H., Maruyama, S., Yuzawa, Y., Kato, T., Miki, Y., Suzuki, S., Sato, W., Morita, Y., Maruyama, H., Egashira, K., and Matsuo, S. (2003). Anti-monocyte chemoattractant protein-1 gene therapy attenuates renal injury induced by protein-overload proteinuria. J. Am. Soc. Nephrol., 14, 1496-1505.
72. Smith, S.C. and Allen, P.M. (1991). Myosin-induced acute myocarditis is a T cell-mediated disease. J. Immunol., 147, 2141-2147.
73. Wada, T., Furuichi, K., Sakai, N., Iwata, Y., Kitagawa, K., Ishida, Y., Kondo, T., Hashimoto, H., Ishiwata, Y., Mukaida, N., Tomosugi, N., Matsushima, K., Egashira, K., and Yokoyama, H. (2004). Gene therapy via blockade of monocyte chemoattractant protein-1 for renal fibrosis. J. Am. Soc. Nephrol., 15, 940-948.
74. Wang, Y.C., Herskowitz, A., Gu, L.B., Kanter, K., Lattouf, O., Sell, K.W., and Ahmed-Ansari, A. (1991). Influence of cytokines and immunosuppressive drugs on major histocompatibility complex class I/II expression by human cardiac myocytes in vitro. Hum. Immunol., 31, 123-133.
75. Wegmann, K.W., Zhao, W., Griffin, A.C., and Hickey, W.F. (1994). Identification of myocardiogenic peptides derived from cardiac myosin capable of inducing experimental allergic myocarditis in the Lewis rat. The utility of a class II binding motif in selecting self-reactive peptides. J. Immunol., 153, 892-900.
76. Zwaka, T.P., Manolov, D., Ozdemir, C., Marx, N., Kaya, Z., Kochs, M., Hoher, M., Hombach, V., and Torzewski, J. (2002). Complement and dilated cardiomyopathy: A role of sublytic terminal complement complex-induced tumor necrosis factor-Alpha synthesis in cardiac myocytes. Am. J. Pathol., 161, 449-457.